Vermersch P, et al. The EXPAND Study Results: Efficacy of Siponimod in Secondary Progressive Multiple Sclerosis. EAN 2017, O1217.
ECTRIMS 2015 video update Bouma: Parallel Session 2 New challenges in clinical trial design
jun 2017
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen